Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Exxon Mobil Corporation — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Exxon Mobil Corporation trades at $178.39 (market cap $727.85B). The key difference: Exxon Mobil Corporation is far larger — about 85.9× Hinge Health Inc. Class A Common Stock's market cap, and Exxon Mobil Corporation pays a 2.33% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Exxon Mobil Corporation for 100 Days on average.
| HNGE | XOM | |
|---|---|---|
Market Cap | $8.47B | $727.85B |
Volume | 1,624,526 | 10,493,203 |
Sector | Health | Energy |
52-Week High | $105.14 | $177.06 |
52-Week Low | $31.17 | $110.64 |
Typical Hold Time | 0 Days | 100 Days |
Enterprise Value | $8.09B | $759.63B |
Dividend Yield | — | 2.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
ExxonMobil (XOM) trades at $174.13, up 1.15% with a bullish technical signal from moving averages. The company maintains strong profitability with 9.07% net margin and 12.55% ROE, though revenue declined to $323.91B in 2025. Recent developments include negotiations to return to Venezuela's oil fields and expansion in Guyana and Permian Basin assets targeting 5.5 MMBoe/d production by 2030.
XOM presents a mixed outlook with analyst consensus at Hold (56.37%) and $166.67 price target below current levels. Upside potential exists from strategic expansions and LNG market growth, but risks include declining revenue trends, geopolitical exposure in Venezuela, and refinery operational challenges. The stock trades near resistance at $174 with RSI indicating overbought conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
